Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study

Arch Dermatol. 1988 Dec;124(12):1802-4.

Abstract

Sunscreens block the absorption of the sunlight spectrum responsible for the cutaneous synthesis of vitamin D (ultraviolet B). The present study was prompted by our observation of suppression of cutaneous vitamin D formation by a single application of sunscreening agents. We measured the index of vitamin D body store, serum 25-hydroxyvitamin D (25-OH-D) level, in 20 long-term users of p-aminobenzoic acid (PABA) and in 20 controls matched by age and exposure to sunlight. Serum 25-OH-D levels were significantly lower among long-term PABA users than among normal controls: 40.2 +/- 3.2 vs 91.3 +/- 6.2 nmol/L. Furthermore, vitamin D deficiency, ie, 25-OH-D levels below 20.0 nmol/L, was seen in two PABA users and in none of the controls. This preliminary study suggests that long-term use of PABA may be associated with low body stores of vitamin D in some persons.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Calcifediol / blood*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Seasons
  • Skin Neoplasms / prevention & control
  • Sunscreening Agents / adverse effects*
  • Time Factors
  • Vitamin D Deficiency / chemically induced

Substances

  • Sunscreening Agents
  • Calcifediol